Back to today’s briefing

Story perspectives

BillionToOne Soars 82% on Nasdaq Debut, Valued at $4.8B

11/7/2025

27 5

Summary

Story summary

BillionToOne Inc. debuted on the Nasdaq with shares priced at $60, raising $273.1 million in an upsized IPO.
The stock surged 82% on its first day and closed at $108.94, yielding a $4.8 billion market value.
BillionToOne focuses on precision molecular diagnostics, including non-invasive prenatal testing and oncology.
Despite a net loss of $4.2 million in the first half of the year, the IPO positions the company for growth.

1 of 1

Story summary

BillionToOne Inc. debuted on the Nasdaq with shares priced at $60, raising $273.1 million in an upsized IPO.
The stock surged 82% on its first day and closed at $108.94, yielding a $4.8 billion market value.
BillionToOne focuses on precision molecular diagnostics, including non-invasive prenatal testing and oncology.
Despite a net loss of $4.2 million in the first half of the year, the IPO positions the company for growth.